Robot maker Agibot has revealed the next phase of its humanoid robot program, and it involves being able to rent your own robot instead of buying outright.

Navigating drug coverage demands brain power in our DIY retirement system, and it isn’t getting any easier. While President Donald Trump has launched TrumpRx and other initiatives to lower costs, ...

ARS Pharmaceuticals (NASDAQ:SPRY) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline early commercial progress for neffy, its needle-free epinephrine option for ...

Discover practical Google search tips, powerful Google search operators, and advanced Google search tricks to find accurate, relevant information faster and refine every search like a pro. Pixabay, ...

Good day, and thank you for standing by. Welcome to the Alvotech Q4 2025 and Full Year 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being ...

Alvotech (NASDAQ:ALVO) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline progress on commercial launches, manufacturing and quality initiatives tied to recent U.

The FDA’s independent vaccine advisers unanimously voted Thursday to recommend that U.S. flu shot formulations for the next ...

GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced employer-sponsored access ...

Rep. Mike Bost, R-Ill., wants to develop a "must-pass" authorization bill process for the VA similar to the legislative procedure used to approve the NDAA.

Search Console is a free gift from Google for SEO professionals that tells you how your website is performing. It’s the closest thing to X-ray vision we can get. With data-packed amenities, SEO ...

That has left us in both a financially strong position with $184 million of ARR, continuing with a greater than 100% NRR. Long-term relationships with our customers on average, 5 years with some of ...

For most products, “Made in the USA” is a point of pride.For medicine, it may be about safety.After months of investigating drug manufacturing overseas, we foun ...